retatrutide not for human consumption Since January 2026, there have been six cases of acute liver toxicity associated with unapproved peptide products labelled in Australia. These toxic effects may be linked to a contaminant in the Bulk Retatrutide Research Supply |

Patients considering combination protocols should work with experienced practitioners familiar with peptide interactions and dosing improvement

Commonly reported adverse effects include: Gastrointestinal symptoms nausea, vomiting, diarrhoea, and constipation were the most frequently reported side effects, particularly during dose escalation

If this is your first IV Nutrient Therapy or Vitamin Booster appointment, please allow up to 30 minutes for your initial consultation and prescribing process

This can lead to dehydration and electrolyte imbalances

Some patients also benefit from occasional maintenance sessions every 6-12 months to preserve their results